Columbia University

Technology Ventures

Latest News

Columbia Engineering’s photonics experts, including Professors Keren Bergman, Michal Lipson, and Alex Gaeta, are an integral part of an exciting new Integrated Photonics Manufacturing Innovation Hub in Rochester, NY, announced by Vice President Joseph Biden at a press conference on July 27.
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
Can two entrepreneurs turn neuroscience into Moneyball?
Researchers at Columbia University Medical Center (CUMC) have found that key parts of the human brain network that give us the power to control and redirect our attention—a core cognitive ability—may be unique to humans.
Gordana Vunjak-Novakovic’s research is making it possible to engineer human bone and build parts of the heart and lung.
A key to better detecting the truth could reside in a person’s verbal cues, according to Julia Hirschberg, Percy K. and Vida L.W. Hudson Professor and Chair of Computer Science.
Research from Eric Kandel’s lab at Columbia University Medical Center (CUMC) has uncovered further evidence of a system in the brain that persistently maintains memories for long periods of time. And paradoxically, it works in the same way as mechanisms that cause mad cow disease, kuru, and other degenerative brain diseases.
Columbia Engineering excelled in the University’s Research Initiatives in Science & Engineering (RISE) competition, held annually to fund interdisciplinary teams of faculty-level researchers pursuing early stages of imaginative, high-risk, and potentially high-impact research collaborations
Columbia University’s ultraviolet (UV) light technology has been licensed to USHIO Inc., a Tokyo-based developer, manufacturer, and marketer of light sources and instruments.
Following the June 9, 2015 Future of Urban Innovation: Startups conference in New York City, Columbia University and Mitogen announce a partnership to attract investment for its first-in-class implant that regenerates the body’s own tissue.